Transcription is a complex process controlled at various steps, such as initiation, elongation, and termination (1-4). Recently, it has become evident that expression of several cellular and virus genes is regulated at the transcription elongation step (5-8). So far, multiple transcription elongation factors, such as S-II (TFIIS) (9, 10), elongin (SIII) (11, 12) , , 17) and ELL (18), have been identified.
Transcription is a complex process controlled at various steps, such as initiation, elongation, and termination (1) (2) (3) (4) . Recently, it has become evident that expression of several cellular and virus genes is regulated at the transcription elongation step (5) (6) (7) (8) . So far, multiple transcription elongation factors, such as S-II (TFIIS) (9, 10) , elongin (SIII) (11, 12) , TFIIF (13) (14) (15) , TEF-b (16, 17) and ELL (18) , have been identified.
Among them, S-II was originally purified and characterized from mouse Ehrlich ascites tumor cells as a specific stimulatory protein of RNA polymerase II (9, 10, (19) (20) (21) . Subsequently, S-II has been identified in various organisms and shown to make RNA polymerase II read-through intrinsic blocks within the transcription units of eukaryotic genes, in vitro, by promoting cleavage of the 3'-end of the nascent RNA by RNA polymerase II (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) .
To investigate the cellular functions of S-II in eukaryotic transcription, we have been studying S-II from yeast (Saccharomyces cerevisiae) (33) (34) (35) .
The yeast S-II null mutant is viable, but becomes sensitive to 6-azauracil (6-AU) (34, 36) . By creating various deletion mutants of S-II, we found that the C-terminal 147 amino acid residues are sufficient for the stimulation of RNA polymerase II and suppression of 6-AU sensitivity (34) .
Furthermore, by creating chimeric molecules of mouse and yeast S-II, we found that the region between Pro-131 and Phe-270 is responsible for the species-specific interaction of S-II and RNA polymerase II (35) . These by guest on http://www.jbc.org/ Downloaded from results suggested that the 6-AU sensitivity of the S-II null mutant is caused by loss of function of S-II as a transcription elongation factor. However, the target gene(s) for S-II that confers yeast resistance to 6-AU has not yet been identified.
To gain more insight into the role of S-II in the sensitivity of yeast to 6-AU, we have identified a gene, SSM1, that suppresses sensitivity to 6-AU.
We found that S-II enhances transcription of the SSM1 gene, resulting in suppression of the sensitivity of the S-II null mutant to 6-AU.
Materials and Methods

Isolation of Clones Suppressing the 6-AU Sensitivity of the S-II Null
Mutant -The yeast S-II null mutant (TNY14) (34) was transfected with multi-copy type genomic clones of Saccharomyces cerevisiae with an average insert size of 10 kbp constructed in YEp13 by the method of Gietz et al. (1992) (37) . Clones that formed colonies on EMD (0.67% yeast nitrogen base without amino acids, 0.5% casamino acids technical and 2% glucose) plates containing 100 µg/ml of 6-AU were selected.
To determine the gene responsible for the suppression of 6-AU sensitivity, various deletion mutants of the multi-copy clone that suppressed 6-AU sensitivity were created by PCR, subcloned into YEp13, and transfected to TNY14 to examine suppression of 6-AU sensitivity.
Plasmids were recovered from the transformants by the method of by guest on http://www.jbc.org/ Downloaded from the SSM1 null mutant, we introduced the PCR product into the TNY04 strain (33) . For isolation of the SSM1/S-II double null mutant, we introduced it into the TNY03 (TNY04/s-ii::LEU2) strain. The resulting colonies were examined for disruption of the SSM1 ORF by colony PCR (41) using primers corresponding to the 5'-and 3'-flanking regions of the SSM1 gene (-35 to -12 and +1130 to +1150). 
Northern Blotting Analysis
Results
Isolation of a DNA Fragment (pR1) that Suppresses 6-Azauracil
Sensitivity of the S-II Null Mutant -Previously, we found that when the yeast S-II gene was disrupted, the resulting S-II null mutants became sensitive to 6-AU (34, 36) . Therefore, we looked for genes that suppress the 6-AU sensitivity of S-II null mutants. For this, we transfected multicopy type genomic clones of Saccharomyces cerevisiae with an average insert size of 10 kbp constructed in YEp13 into TNY14 (an S-II null mutant), and isolated the colonies formed on a plate containing 100 µg/ml 6-AU. Of 91,000 transformants examined, 11 clones were resistant to 6-AU. Southern blot analysis of plasmids recovered from these clones using S-II cDNA as a probe revealed that 8 of the 11 clones were transfected with S-II DNA. Restriction maps of the plasmids recovered from the remaining three clones were identical, indicating that these clones were the same (data not shown). We further analyzed this plasmid (pR1), which contained a 12 -kbp insert.
To restrict the region of pR1 needed to suppress the 6-AU sensitivity of TNY14, we created various deletion mutants of pR1 and examined whether they were able to suppress 6-AU sensitivity. As shown in Fig. 1 , we first by guest on July 17, 2017
http://www.jbc.org/ Downloaded from examined four clones (pR3, pR5, pR14 and pR15) and found that pR5 and pR14 suppressed 6-AU sensitivity. As pR14 was a part of pR5, we further prepared four deletion mutants of pR14 (pR17, pR22, pR23 and pR27) and found that pR17 was sufficient for the suppression of 6-AU sensitivity. We determined the nucleotide sequence of pR17, and found that it contained an ORF encoding 280 amino acid residues. We named this protein SSM1( To examine whether in fact SSM1 has the ability to suppress 6-AU sensitivity, we over-expressed the SSM1 gene in TNY14 under the control of the GAL1 promoter. As shown in Fig. 3 , TNY14 expressing SSM1 formed colonies on a plate containing 6-AU, indicating that SSM1 is responsible for conferring 6-AU resistance to TNY14. with homologous RNA polymerase II (35) . Therefore, to examine whether a specific interaction of S-II and RNA polymerase II is indispensable for S-II to enhance the expression of the SSM1 gene, we separately expressed four chimeric S-II molecules in the S-II null mutant. These chimeric S-II molecules are the same as those we used previously to demonstrate a species-specific interaction between S-II and RNA polymerase II (Fig. 7A ).
Analysis of Deletion Mutant of SSM1
We have shown that almost equivalent amounts of chimeric S-II molecules are generated when cDNAs for these molecules are expressed in an E. coli expression system, as determined by immunoblotting (35) .
As shown in Fig. 7B , expression of the SSM1 gene in TNY14 was enhanced only when wild type S-II or EYE was introduced. Introduction of mouse S-II or YEY did not seem to cause appreciable enhancement of SSM1 gene transcription. To quantify the transcription of the SSM1 gene in these transformants, intensity of the signals in Fig. 7B was scanned and the amounts relative to that in the wild type strain were calculated (Table I) .
Level of SSM1 mRNA in TNY14 was less than 1/3 of that in the wild type strain. This level was increased to the wild type strain level when Y or EYE was introduced, but introduction of E or YEY did not change this were detected when the other three fragments were employed. As only fragment 1 contains the 5'-upstream region of SSM1 cDNA, the arrest sites were assumed to be located in this region.
We identified these arrest sites by nucleotide substitution experiments (45) . As shown in Fig. 9A , we created three fragment 1 mutants. In mutants 1 and 2, 10 bases corresponding to positions 101 to 110 and 111 to than those obtained when wild type fragment 1 was used as template, as shown in Fig. 9B . On the other hand, both bands became fainter when mutant 3 was used as a template. These results suggest that the two arrest sites are located in positions 101 to 110 and 111 to 120. These arrest sites seemed to be read through by RNA polymerase II when S-II was present.
As shown in Fig. 10 , the intensity of both bands decreased on addition of recombinant S-II to the reaction mixture.
Discussion
It is clear that the SSM1 gene is responsible for the sensitivity of TNY14 (a S-II null mutant) to 6-AU. Expression of the SSM1 gene in Nothing is known about the function of SSM1. It was difficult to predict the function of SSM1 from its amino acid sequence, as no appreciable functional domains were identified. SSM1 could be an enzyme that inactivates 6-AU by modifying it. It could also be a protein that represses the uptake of 6-AU. Extensive biochemical studies are needed to elucidate the function of SSM1 in suppressing the toxicity of 6-AU at 100 µg/ml to TNY14. Nevertheless, our finding that SSM1 suppresses the sensitivity of TNY14 to 6-AU is important, because for the first time it gave a clue to the function of S-II in vivo.
Sensitivity to 100 µg/ml 6-AU is the only phenotype so far identified for the S-II null mutant (33, 34, 36) . Except for the S-II gene, the SSM1 gene was the only gene that reversed this phenotype, and we found that expression of the SSM1 gene was controlled by S-II. It may be important to identify other phenotypes, and the genes responsible for them, in S-II null mutants. If these genes have similar transcription arrest sites as those in the SSM1 gene, it may be possible to extend the function of S-II to all these genes.
Legends to Figures   Fig. 1 Mapping of the SSM1 gene on yeast chromosome DNA.
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